Pharma Equity Group A/S Cl A (PEG) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.136x

Based on the latest financial reports, Pharma Equity Group A/S Cl A (PEG) has a cash flow conversion efficiency ratio of -0.136x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-6.66 Million ≈ $-1.04 Million USD) by net assets (Dkr48.88 Million ≈ $7.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Pharma Equity Group A/S Cl A's balance sheet to measure how much of total assets are equity-financed.

Pharma Equity Group A/S Cl A - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Pharma Equity Group A/S Cl A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pharma Equity Group A/S Cl A (PEG) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Pharma Equity Group A/S Cl A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharma Equity Group A/S Cl A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kiriacoulis Mediterranean Cruises Shipping S.A. AT:KYRI	N/A
Xavis Co. Ltd KQ:254120	0.045x
Black Rock Mining Ltd AU:BKT	-0.062x
Aberforth Smaller Companies Trust PLC LSE:ASL	0.015x
Resource Development Group Ltd AU:RDG	0.082x
Olympia Industries Bhd KLSE:3018	0.024x
Zhonglu Co Ltd B SHG:900915	0.056x
S&K Polytec Co. Ltd KQ:091340	0.034x

Annual Cash Flow Conversion Efficiency for Pharma Equity Group A/S Cl A (2009–2025)

The table below shows the annual cash flow conversion efficiency of Pharma Equity Group A/S Cl A from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Pharma Equity Group A/S Cl A worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	Dkr25.47 Million ≈ $3.99 Million	Dkr-17.66 Million ≈ $-2.76 Million	-0.693x	-48.23%
2024-09-30	Dkr48.88 Million ≈ $7.65 Million	Dkr-22.86 Million ≈ $-3.58 Million	-0.468x	+28.72%
2023-09-30	Dkr25.33 Million ≈ $3.96 Million	Dkr-16.62 Million ≈ $-2.60 Million	-0.656x	-951.34%
2022-09-30	Dkr46.05 Million ≈ $7.20 Million	Dkr-2.87 Million ≈ $-449.66K	-0.062x	-27.18%
2021-09-30	Dkr42.57 Million ≈ $6.66 Million	Dkr-2.09 Million ≈ $-326.84K	-0.049x	+83.01%
2020-09-30	Dkr34.28 Million ≈ $5.36 Million	Dkr-9.90 Million ≈ $-1.55 Million	-0.289x	-6981.66%
2019-09-30	Dkr67.16 Million ≈ $10.51 Million	Dkr-274.00K ≈ $-42.87K	-0.004x	+79.96%
2018-09-30	Dkr77.57 Million ≈ $12.14 Million	Dkr-1.58 Million ≈ $-247.05K	-0.020x	+64.80%
2017-09-30	Dkr85.09 Million ≈ $13.31 Million	Dkr-4.92 Million ≈ $-769.93K	-0.058x	-2992.17%
2016-09-30	Dkr96.78 Million ≈ $15.14 Million	Dkr-181.00K ≈ $-28.32K	-0.002x	+93.66%
2015-09-30	Dkr99.53 Million ≈ $15.57 Million	Dkr-2.94 Million ≈ $-459.67K	-0.030x	+39.77%
2014-09-30	Dkr97.95 Million ≈ $15.32 Million	Dkr-4.80 Million ≈ $-750.99K	-0.049x	-189.26%
2013-09-30	Dkr-105.44 Million ≈ $-16.50 Million	Dkr-5.79 Million ≈ $-905.73K	0.055x	+118.92%
2012-09-30	Dkr36.39 Million ≈ $5.69 Million	Dkr-10.56 Million ≈ $-1.65 Million	-0.290x	-304.66%
2011-09-30	Dkr79.67 Million ≈ $12.46 Million	Dkr-5.71 Million ≈ $-893.84K	-0.072x	+78.56%
2010-09-30	Dkr53.06 Million ≈ $8.30 Million	Dkr-17.75 Million ≈ $-2.78 Million	-0.334x	-2303.51%
2009-09-30	Dkr53.47 Million ≈ $8.37 Million	Dkr-744.00K ≈ $-116.40K	-0.014x	--

About Pharma Equity Group A/S Cl A

CO:PEG Denmark Biotechnology

Market Cap

$16.71 Million

Dkr106.80 Million DKK

Market Cap Rank

#25657 Global

#116 in Denmark

Share Price

Dkr0.09

Change (1 day)

+1.16%

52-Week Range

Dkr0.07 - Dkr0.15

All Time High

Dkr2.81